| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/28/2005 | WO2004049907A3 Compositions and methods for treating transplants |
| 04/28/2005 | US20050090689 Such as gadolinium complexes of 10-[2-[(3,5-Bis[[(2,3-dihydroxypropyl)amino]-carbonyl]phenyl]amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid; for use as contrast agents, X-ray imaging, radionuclide imaging, ultrasound imaging and magnetic resonance imaging; biocompatability |
| 04/28/2005 | US20050089951 Method for labeled amidation of biological molecule and method for analyzing biological molecule |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells |
| 04/28/2005 | US20050089523 Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids |
| 04/28/2005 | US20050089511 Methods and compositions comprising DNA damaging agents and p53 |
| 04/28/2005 | US20050089471 A reaction product of an antibody, protein, biomolecule, polysaccharide, or peptidomimetic, a luminescent dye, radionuclide, near infrared dye, a magnetically active isotope, a superparamagnetic particle, or a metal ion, and a linker moiety; diagnosis and monitoring of inflammatory diseases |
| 04/27/2005 | EP1525223A2 Ox40 (=cd134) receptor agonists and therapeutic use |
| 04/27/2005 | EP1524984A1 Myocardial perfusion imaging using a2a receptor agonists |
| 04/27/2005 | EP1121153B1 Site-specific labeling of disulfide-containing targeting vectors |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884817 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases |
| 04/26/2005 | US6884417 Sepsis |
| 04/21/2005 | WO2005035005A1 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
| 04/21/2005 | WO2005034926A2 Non-invasive system for detecting skin cancer |
| 04/21/2005 | WO2005034912A2 Ferromagnetic particles and methods |
| 04/21/2005 | WO2004018066A3 Aqueous two-phase systems for particle manipulation and encapsulation within microscopic volumes |
| 04/21/2005 | US20050085417 Compounds and methods for diagnostic imaging and therapy |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084451 Novel chelating agents and chelates and their use |
| 04/21/2005 | US20050084449 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof |
| 04/21/2005 | US20050084448 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 04/21/2005 | US20050084447 Radioligands for the TRP-M8 receptor and methods therewith |
| 04/20/2005 | EP1523995A2 Patient-specific dosimetry |
| 04/20/2005 | EP1523337A2 Imaging method and device for carrying out said method |
| 04/20/2005 | EP1307446B1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 04/20/2005 | EP1218351B1 Nitroimidazole derivative and diagnostic imaging agent containing the same |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/19/2005 | US6881396 Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | US6881183 Radioactive seed with multiple markers and method for using same |
| 04/19/2005 | CA2138150C 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides |
| 04/14/2005 | WO2005033652A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 04/14/2005 | WO2005033313A2 Intracelluar trapping of radionuclides by enzyme-mediated reduction |
| 04/14/2005 | WO2005032599A1 Chelate based scaffolds in tumor targeting |
| 04/14/2005 | WO2005032598A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 04/14/2005 | WO2005011738A3 Polymeric conjugates containing phosphine - based chelating groups |
| 04/14/2005 | WO2004093650A3 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 04/14/2005 | WO2004072105A3 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 04/14/2005 | WO2004062574A3 Improved linkers for radiopharmaceutical compounds |
| 04/14/2005 | US20050080130 Compounds foriImaging alzheimer's disease |
| 04/14/2005 | US20050080064 Steroids as agonists for fxr |
| 04/14/2005 | US20050079564 Test agents for evaluating pharmacological effect of drug and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or prodrugs thereof |
| 04/14/2005 | US20050079133 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 04/14/2005 | US20050079131 Oil nanoparticle overcoated with lipid, surfactant mixture; oil in water emulsions; contrast for magnetic resonance imaging |
| 04/14/2005 | CA2840691A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 04/14/2005 | CA2540131A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 04/14/2005 | CA2530789A1 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 04/13/2005 | EP1521775A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 04/13/2005 | CN1196498C Preparing box for polysaccharide compounding substance |
| 04/12/2005 | US6878550 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control |
| 04/12/2005 | US6878363 Administering a diagnostically effective amount of a radiopharmaceutical inhibitor of amyloid protein precursor (APP) processing and/or the production of beta- amyloid production; imaging the area of disease in a patient |
| 04/07/2005 | WO2005031758A2 Method for producing carrier-free 72as, device for automatically producing carrier-free 72as, carrier-free 72as(iii) halide, and use thereof |
| 04/07/2005 | WO2005009393A3 Stable radiopharmaceutical compositions and methods for preparation |
| 04/07/2005 | WO2004098651A3 Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy |
| 04/07/2005 | WO2004032857A8 Antibody therapy |
| 04/07/2005 | US20050074402 Radiopharmaceutical formulations |
| 04/07/2005 | US20050074401 Selective targeting of tumor vasculature using radiolabelled antibody molecules |
| 04/07/2005 | CA2531894A1 Inherently radiopaque polymeric products for embolotherapy |
| 04/06/2005 | EP1520588A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519917A2 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/05/2005 | US6875886 Modified PSMA ligands and uses related thereto |
| 04/05/2005 | US6875864 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 04/05/2005 | CA2145509C 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them |
| 03/31/2005 | WO2005029066A2 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 03/31/2005 | WO2005028490A1 Halogenated deoxy-glucose labeled targeting molecules |
| 03/31/2005 | WO2005028021A2 Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy |
| 03/31/2005 | WO2005027981A1 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 03/31/2005 | WO2004075819A3 Activation and production of radiolabeled particles |
| 03/31/2005 | WO2004010951A8 Method of treating tumors |
| 03/31/2005 | US20050070693 Chimeric monoclonal antibody specific to leukocyte receptor for use as tool in treatment and prevention of cell proliferative, autoimmune, prion, liver and inflammatory disorders; immunotherapy |
| 03/31/2005 | US20050070470 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/31/2005 | US20050070466 Diagnostic imaging agents; targeting vectors which bind to integrin receptors; bicyclic arginine-glycine-aspartic acid derivatives; stablility; reduced background interference |
| 03/31/2005 | US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/31/2005 | US20050069961 Isotope-coded affinity tag |
| 03/31/2005 | US20050069547 Binding protein; therapy for bone tumors |
| 03/31/2005 | US20050069542 Antibodies that specifically bind to GMAD |
| 03/31/2005 | US20050069495 For therapy of malignant tumor |
| 03/31/2005 | US20050069494 Polypeptide; magnetic resonance imaging; diagnosis of cancer, osteoarthritis, infections, oral disease, rheumatic diseaeses, antiarthritic agents , cardiovascular disorders |
| 03/31/2005 | US20050069493 Administering a cobalamin linked with a diamino compound to a chelating group of a detectable metal, such as a radionuclide or paramagnetic metal ion |
| 03/30/2005 | EP1518562A2 Dopamine transporter imaging agents |
| 03/30/2005 | EP1518561A2 Dopamine transporter imaging agents |
| 03/30/2005 | EP1517919A2 Marked peptides having affinity for a phospholipid and uses |
| 03/30/2005 | EP1517909A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/30/2005 | EP1517903A2 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules |
| 03/30/2005 | EP1395226A4 Use of radiopharmaceutical complexes in achieving transplantation tolerance |
| 03/30/2005 | CN1194979C Medical radioactive rhenium-aminophosphonic acid compound and preparing process thereof |
| 03/30/2005 | CN1194764C Use of radium-223 in preparing medicine for treating bone affected diseases |
| 03/29/2005 | US6872804 Glycopeptide for use in the prevention and treatment of bacterial infections |
| 03/29/2005 | US6872701 Glycopeptide phosphonate derivatives |
| 03/29/2005 | US6872536 Chemotactic peptide antagonists for imaging sites of inflammation |
| 03/29/2005 | US6872516 Methods of producing carbon-13 labeled biomass |
| 03/29/2005 | US6872381 Such as 1-(5-chloro-2-(2-((2R)-4-(4-fluoro-18F-benzyl)-2-methylpiperazin-1-yl)-2 -oxoethoxy)phenyl)urea for binding chemokine receptors in brain tissue; tomography |
| 03/29/2005 | CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 03/24/2005 | WO2005026325A2 Bivalent targeting of cell surfaces |
| 03/24/2005 | WO2005025519A2 Radiolabeled thymidine solid-phase extraction purification method |